Molnupiravir is an oral antiviral drug developed to provide significant benefit in reducing
hospitalizations or deaths in mild COVID-19. Integrated green computational …

Nowadays, the analytical community is focusing on developing new analytical methods that
incorporate principles of green analytical chemistry to reduce adverse impacts on the …

The endemicity of the pandemic coronavirus disease 2019 (COVID‐19) infection proved to
be transitional only. Spikes are forming again in 2023, and high expectations are returning …

Following the spread of the COVID-19 pandemic crisis, a race was initiated to find a
successful regimen for postinfections. Among those trials, a recent study declared the …

An accurate, sensitive and selective RP-HPLC-UV method has been established for the
estimation of Molnupiravir (MOL) in pure bulk powder and pharmaceutical formulation …

Sofosbuvir (SOF) and velpatasvir (VEL) are recently co-formulated together for the treatment
of hepatitis C virus. Smart and robust spectrophotometric methods were first developed and …

Molnupiravir is the first oral direct-acting antiviral prodrug recently approved for the COVID-
19 pandemic. Here and for the first time, we present a novel, sensitive, robust, and simple …

The present work describes development of rapid, robust, sensitive and green
spectrofluorimetric method for determination of favipiravir (FAV). Different factors affecting …

Hydroxychloroquine (HCQ) and favipiravir (FPV) are known to be effective antivirals, and
there are reports about their use to fight the severe acute respiratory syndrome coronavirus …

Favipiravir, remdesivir and hydroxychloroquine have been suggested in COVID-19
Treatment Guidelines Panel of many countries. Synchronous spectrofluorometric …